LIPM
gene geneOn this page
Also known as bA304I5.1
Summary
LIPM (lipase family member M, HGNC:23455) is a protein-coding gene on chromosome 10q23.31, encoding Lipase member M (Q5VYY2). Plays a highly specific role in the last step of keratinocyte differentiation.
Predicted to enable lipoprotein lipase activity. Predicted to be involved in cornification. Predicted to be located in extracellular region.
Source: NCBI Gene 340654 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 45 total
- MANE Select transcript:
NM_001128215
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23455 |
| Approved symbol | LIPM |
| Name | lipase family member M |
| Location | 10q23.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA304I5.1 |
| Ensembl gene | ENSG00000173239 |
| Ensembl biotype | protein_coding |
| OMIM | 613923 |
| Entrez | 340654 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000404743, ENST00000539337
RefSeq mRNA: 1 — MANE Select: NM_001128215
NM_001128215
CCDS: CCDS44457
Canonical transcript exons
ENST00000404743 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001006983 | 88808298 | 88808415 |
| ENSE00001097597 | 88816816 | 88816887 |
| ENSE00001097600 | 88817825 | 88817896 |
| ENSE00001097602 | 88815357 | 88815503 |
| ENSE00001097605 | 88814530 | 88814639 |
| ENSE00001097611 | 88815088 | 88815224 |
| ENSE00001551500 | 88802730 | 88803043 |
| ENSE00002522684 | 88813097 | 88813295 |
| ENSE00003903572 | 88820232 | 88820546 |
Expression profiles
Bgee: expression breadth broad, 39 present calls, max score 85.94.
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of leg | UBERON:0001511 | 85.94 | gold quality |
| zone of skin | UBERON:0000014 | 85.68 | gold quality |
| skin of abdomen | UBERON:0001416 | 85.23 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 50.41 | silver quality |
| body of stomach | UBERON:0001161 | 46.66 | gold quality |
| granulocyte | CL:0000094 | 45.60 | silver quality |
| stomach | UBERON:0000945 | 44.10 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 43.70 | silver quality |
| blood | UBERON:0000178 | 42.66 | gold quality |
| vermiform appendix | UBERON:0001154 | 42.60 | gold quality |
| colonic epithelium | UBERON:0000397 | 42.55 | gold quality |
| fundus of stomach | UBERON:0001160 | 40.46 | gold quality |
| rectum | UBERON:0001052 | 39.43 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 38.47 | silver quality |
| bone marrow cell | CL:0002092 | 38.37 | gold quality |
| bone marrow | UBERON:0002371 | 38.05 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.38 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle tissue | UBERON:0002385 | 35.22 | gold quality |
| monocyte | CL:0000576 | 34.29 | gold quality |
| body of pancreas | UBERON:0001150 | 33.51 | gold quality |
| vagina | UBERON:0000996 | 33.49 | gold quality |
| lymph node | UBERON:0000029 | 33.02 | gold quality |
| omental fat pad | UBERON:0010414 | 32.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| multicellular organism | UBERON:0000468 | 31.69 | gold quality |
| pancreas | UBERON:0001264 | 31.63 | silver quality |
| gall bladder | UBERON:0002110 | 31.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.43 |
Regulation
Is transcription factor: no
Cross-species orthologs
30 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lipm | ENSMUSG00000056078 |
| rattus_norvegicus | Lipm | ENSRNOG00000019301 |
| drosophila_melanogaster | Lip3 | FBGN0023495 |
| drosophila_melanogaster | Lip1 | FBGN0023496 |
| drosophila_melanogaster | Lip2 | FBGN0024740 |
| drosophila_melanogaster | CG2772 | FBGN0031533 |
| drosophila_melanogaster | Lip4 | FBGN0032264 |
| drosophila_melanogaster | CG18301 | FBGN0032265 |
| drosophila_melanogaster | CG18302 | FBGN0032266 |
| drosophila_melanogaster | CG7329 | FBGN0032271 |
| drosophila_melanogaster | CG3635 | FBGN0032981 |
| drosophila_melanogaster | CG8093 | FBGN0033999 |
| drosophila_melanogaster | CG11406 | FBGN0034990 |
| drosophila_melanogaster | mag | FBGN0036996 |
| drosophila_melanogaster | CG11598 | FBGN0038067 |
| drosophila_melanogaster | CG11600 | FBGN0038068 |
| drosophila_melanogaster | CG11608 | FBGN0038069 |
| drosophila_melanogaster | CG6753 | FBGN0038070 |
| drosophila_melanogaster | CG18530 | FBGN0042207 |
| drosophila_melanogaster | CG18284 | FBGN0043825 |
| drosophila_melanogaster | CG31089 | FBGN0051089 |
| drosophila_melanogaster | CG31091 | FBGN0051091 |
| drosophila_melanogaster | CG31871 | FBGN0051871 |
| drosophila_melanogaster | CG31872 | FBGN0051872 |
| drosophila_melanogaster | CG17097 | FBGN0265264 |
| caenorhabditis_elegans | WBGENE00009773 | |
| caenorhabditis_elegans | WBGENE00010062 | |
| caenorhabditis_elegans | WBGENE00020016 | |
| caenorhabditis_elegans | WBGENE00021963 | |
| caenorhabditis_elegans | WBGENE00022642 |
Paralogs (5): LIPA (ENSG00000107798), LIPF (ENSG00000182333), LIPN (ENSG00000204020), LIPK (ENSG00000204021), LIPJ (ENSG00000204022)
Protein
Protein identifiers
Lipase member M — Q5VYY2 (reviewed: Q5VYY2)
Alternative names: Lipase-like abhydrolase domain-containing protein 3
All UniProt accessions (1): Q5VYY2
UniProt curated annotations — full annotation on UniProt →
Function. Plays a highly specific role in the last step of keratinocyte differentiation. May have an essential function in lipid metabolism of the most differentiated epidermal layers.
Subcellular location. Secreted.
Tissue specificity. Exclusively expressed in the epidermis within the granular keratinocytes.
Similarity. Belongs to the AB hydrolase superfamily. Lipase family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VYY2-1 | 1 | yes |
| Q5VYY2-2 | 2 |
RefSeq proteins (1): NP_001121687* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000073 | AB_hydrolase_1 | Domain |
| IPR025483 | Lipase_euk | Family |
| IPR029058 | AB_hydrolase_fold | Homologous_superfamily |
Pfam: PF00561
UniProt features (11 total): active site 3, sequence variant 2, signal peptide 1, chain 1, domain 1, glycosylation site 1, disulfide bond 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VYY2-F1 | 88.92 | 0.71 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 186 (nucleophile); 357 (charge relay system); 386 (charge relay system)
Disulfide bonds (1): 260–269
Glycosylation sites (1): 48
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-6805567 | Keratinization |
MSigDB gene sets: 27 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_LIPID_METABOLIC_PROCESS, GOBP_KERATINIZATION, GOBP_LIPID_CATABOLIC_PROCESS, GOBP_SKIN_DEVELOPMENT, GOMF_TRIACYLGLYCEROL_LIPASE_ACTIVITY, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY, GOMF_LIPASE_ACTIVITY, chr10q23, GOBP_CORNIFICATION, REACTOME_KERATINIZATION, REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE
GO Biological Process (3): lipid metabolic process (GO:0006629), lipid catabolic process (GO:0016042), cornification (GO:0070268)
GO Molecular Function (5): lipoprotein lipase activity (GO:0004465), lipase activity (GO:0016298), hydrolase activity (GO:0016787), hydrolase activity, acting on ester bonds (GO:0016788), carboxylic ester hydrolase activity (GO:0052689)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Keratinization | 1 |
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| hydrolase activity, acting on ester bonds | 2 |
| primary metabolic process | 1 |
| lipid metabolic process | 1 |
| catabolic process | 1 |
| programmed cell death | 1 |
| keratinization | 1 |
| cornified envelope assembly | 1 |
| triacylglycerol lipase activity | 1 |
| catalytic activity | 1 |
| hydrolase activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
964 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LIPM | TFEB | P19484 | 457 |
| LIPM | LIPG | Q9Y5X9 | 433 |
| LIPM | LIPT2 | A6NK58 | 432 |
| LIPM | LIPT1 | Q9Y234 | 428 |
| LIPM | SCGB1D2 | O95969 | 403 |
| LIPM | PLA2G15 | Q8NCC3 | 399 |
| LIPM | TEX30 | Q5JUR7 | 377 |
| LIPM | IGSF22 | Q8N9C0 | 372 |
| LIPM | AASDH | Q4L235 | 368 |
| LIPM | GPR82 | Q96P67 | 361 |
| LIPM | ABHD13 | Q7L211 | 353 |
| LIPM | LIPI | Q6XZB0 | 352 |
| LIPM | ABHD12B | Q7Z5M8 | 351 |
| LIPM | MYBPH | Q13203 | 348 |
| LIPM | FAM135A | Q9P2D6 | 346 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LIPM | CNOT8 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): LIPM (Negative Genetic)
ESM2 similar proteins: A2AIR5, A5D7I4, A8MXE2, A9X1C8, B4F753, B9EKX1, O60242, O60656, O75077, O77485, O77486, O77487, O95803, P16442, P23945, P25291, P97464, Q10981, Q14246, Q16394, Q4R766, Q5GJ04, Q5IGR7, Q5IGR8, Q5M7U7, Q5RBC3, Q5VYY2, Q62452, Q64633, Q64634, Q6AYT7, Q6ZQM8, Q704V6, Q7ZTV5, Q80ZF8, Q8TCU5, Q99LR1, Q9D4Y8, Q9D806, Q9DGB6
Diamond homologs: J3SDX8, O16956, O46107, O46108, O61866, O74430, P04634, P07098, P34163, P38571, P78898, P80035, Q29458, Q3U4B4, Q3YBN2, Q4R4S5, Q5VXI9, Q5VXJ0, Q5VYY2, Q5W064, Q64194, Q67ZU1, Q8BM14, Q8K2A6, Q93789, Q94252, Q9CPP7, Q9Z0M5, Q07950, Q71DJ5, O60095, Q07804
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1223 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:88803044:G:GG | donor_gain | 1.0000 |
| 10:88813093:GCA:G | acceptor_loss | 1.0000 |
| 10:88813095:A:AG | acceptor_gain | 1.0000 |
| 10:88813095:A:G | acceptor_loss | 1.0000 |
| 10:88813096:G:GG | acceptor_gain | 1.0000 |
| 10:88813276:GA:G | donor_gain | 1.0000 |
| 10:88813277:A:G | donor_gain | 1.0000 |
| 10:88815083:TGCA:T | acceptor_loss | 1.0000 |
| 10:88815084:GCAG:G | acceptor_loss | 1.0000 |
| 10:88815086:A:AG | acceptor_gain | 1.0000 |
| 10:88815086:AG:A | acceptor_gain | 1.0000 |
| 10:88815087:G:GA | acceptor_gain | 1.0000 |
| 10:88815087:GG:G | acceptor_gain | 1.0000 |
| 10:88815087:GGCT:G | acceptor_gain | 1.0000 |
| 10:88817824:GGCA:G | acceptor_gain | 1.0000 |
| 10:88803039:ATATT:A | donor_gain | 0.9900 |
| 10:88803040:TATT:T | donor_gain | 0.9900 |
| 10:88803041:ATT:A | donor_gain | 0.9900 |
| 10:88803041:ATTG:A | donor_loss | 0.9900 |
| 10:88803042:TT:T | donor_gain | 0.9900 |
| 10:88803042:TTGT:T | donor_loss | 0.9900 |
| 10:88803044:GTAA:G | donor_loss | 0.9900 |
| 10:88803046:AA:A | donor_loss | 0.9900 |
| 10:88812919:T:A | acceptor_gain | 0.9900 |
| 10:88813095:AG:A | acceptor_gain | 0.9900 |
| 10:88813096:GG:G | acceptor_gain | 0.9900 |
| 10:88813096:GGTT:G | acceptor_gain | 0.9900 |
| 10:88813277:A:AG | donor_gain | 0.9900 |
| 10:88813292:TCAG:T | donor_loss | 0.9900 |
| 10:88813293:CAGGT:C | donor_loss | 0.9900 |
AlphaMissense
2825 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:88813291:T:C | F154L | 0.990 |
| 10:88813293:C:A | F154L | 0.990 |
| 10:88813293:C:G | F154L | 0.990 |
| 10:88813282:T:C | F151L | 0.986 |
| 10:88813284:C:A | F151L | 0.986 |
| 10:88813284:C:G | F151L | 0.986 |
| 10:88813213:T:A | W128R | 0.985 |
| 10:88813213:T:C | W128R | 0.985 |
| 10:88820283:T:A | W352R | 0.984 |
| 10:88820283:T:C | W352R | 0.984 |
| 10:88813174:A:C | S115R | 0.976 |
| 10:88813176:C:A | S115R | 0.976 |
| 10:88813176:C:G | S115R | 0.976 |
| 10:88813294:A:C | S155R | 0.975 |
| 10:88814530:T:A | S155R | 0.975 |
| 10:88814530:T:G | S155R | 0.975 |
| 10:88820277:G:C | A350P | 0.971 |
| 10:88820394:T:C | F389L | 0.971 |
| 10:88820396:C:A | F389L | 0.971 |
| 10:88820396:C:G | F389L | 0.971 |
| 10:88813230:G:C | R133S | 0.969 |
| 10:88813230:G:T | R133S | 0.969 |
| 10:88820379:T:A | W384R | 0.968 |
| 10:88820379:T:C | W384R | 0.968 |
| 10:88813150:T:A | W107R | 0.967 |
| 10:88813150:T:C | W107R | 0.967 |
| 10:88816820:G:C | R288P | 0.965 |
| 10:88820298:G:C | D357H | 0.964 |
| 10:88808383:T:C | I78T | 0.962 |
| 10:88813183:T:C | F118L | 0.962 |
dbSNP variants (sampled 300 via entrez): RS1000067367 (10:88812580 T>A), RS1000354405 (10:88818048 T>A), RS1000423386 (10:88812264 T>C), RS1000465223 (10:88811399 A>G), RS1000922087 (10:88806746 G>A), RS1001583893 (10:88809079 C>T), RS1001794499 (10:88803669 T>C), RS1001795641 (10:88817074 G>T), RS1001910256 (10:88817365 G>A), RS1001983039 (10:88804865 A>G), RS1002196308 (10:88819456 G>T), RS1002206127 (10:88819751 G>A), RS1002591386 (10:88810553 T>C), RS1002786187 (10:88804626 C>T), RS1002916679 (10:88815877 C>T)
Disease associations
OMIM: gene MIM:613923 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 1 |
| sodium arsenate | increases abundance, decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.